Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin (IVIG) in children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
2019-004758-27Phase 4Completed
- Sponsor
- Gillberg Neuropsychiatry Centre
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of immune globulin in pediatric acute-onset neuropsychiatric syndrome (PANS), sponsored by Gillberg Neuropsychiatry Centre. Started Jan 2020; status: completed.
02
Drugs
immune globulin
03
Conditions
pediatric acute-onset neuropsychiatric syndrome (PANS)
Beyond the preview
Go deeper on 2019-004758-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004758-27.